Cargando…
Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism
As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265952/ https://www.ncbi.nlm.nih.gov/pubmed/27684859 http://dx.doi.org/10.1097/MD.0000000000005001 |